# Viracta Therapeutics funding: rounds and investors

> Viracta Therapeutics has raised $18M across 1 round since 2017. Investors include Forward, Latterell and NantKwest/ Wicklow. Every round with its source.

Source: https://millionrounds.com/company/viracta-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Series B startup](https://millionrounds.com/companies)

# Who invested in *Viracta Therapeutics*

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$18M** raised across 1 round since 2017, from 1 source

- **Latest round:** Series B, $18M Apr 2017
- **Investors:** 3

See who backed them

## The rounds

- **Apr 2017** Series B **$18M** [Forward](https://millionrounds.com/fund/forward) Latterell NantKwest/ Wicklow Reported by FinSMEs SEC filing: $9.9M sold, first sale Mar 2017

## Founders and team

From the SEC filings it signed: 2 on the team.

- **Daniel Chevallard** Executive Officer i
- **Ivor Royston** Executive Officer, Director i

On the board, as filed i *Gur Roshwalb* *Michael Huang* *Richard Ghalie* *Roger Pomerantz* *Samuel Murphy*

## Everyone who backed them

[Forward](https://millionrounds.com/fund/forward) Hedge fund **1** round

Latterell no record of our own yet **1** round

NantKwest/ Wicklow no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=viracta-therapeutics).

## Also claim to have backed them

These 2 firms list Viracta Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

[Aisling Capital](https://millionrounds.com/fund/aisling-capital) Private equity Per its own site

[Latterell Venture Partners](https://millionrounds.com/fund/latterell-venture-partners) VC firm Per its own site

## Quick answers about Viracta Therapeutics

### Who invested in Viracta Therapeutics?

Viracta Therapeutics's investors include Forward, Latterell and NantKwest/ Wicklow.

### How much has Viracta Therapeutics raised?

Viracta Therapeutics has raised $18M across 1 round since 2017.

### When did Viracta Therapeutics last raise?

Viracta Therapeutics's most recent round was a Series B of $18M in Apr 2017.

### What was Viracta Therapeutics's biggest round?

Its most recent round, $18M in Apr 2017, is also its largest on record.

### Who backed Viracta Therapeutics first?

Viracta Therapeutics's first round on record, in Apr 2017, was backed by Forward, Latterell and NantKwest/ Wicklow.

### What stage is Viracta Therapeutics at?

Viracta Therapeutics's latest named round is a Series B, in Apr 2017.

### Where is Viracta Therapeutics based?

Viracta Therapeutics is based in the United States.

## Companies like Viracta Therapeutics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app